For the Inventor, By the Inventor

Enter assignee name

Sarasota, FL, United States of America

Rapid Pathogen Screening, Inc.

USPTO Granted Patents = 28

CIPO Patents = 3

EPO Patents = 7

Trademarks = 8

Forward Citations = 136

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Robert P Sambursky (25 out of 26 patents)

Uma Mahesh Babu (22 out of 23 patents)

Robert W VanDine (22 out of 24 patents)

4. Peter Condon (5 out of 5 patents)

5. Franz Aberl (4 out of 5 patents)

6. Marcus Scheibenzuber (4 out of 5 patents)

7. Jose S Sambursky (4 out of 5 patents)

8. Ganga V Kanaujia (3 out of 3 patents)

9. Engelmundus Cornelis Ignatius Veerman (2 out of 5 patents)

10. Thomas Orsini (2 out of 2 patents)

11. Johannes Gerhardus Maria Bolscher (2 out of 3 patents)

12. Arie Van Nieuw Amerongen (2 out of 3 patents)

13. Menno Johannes Oudhoff (2 out of 3 patents)

14. Willem Van't Hof (2 out of 3 patents)

15. Kamran Nazmi (2 out of 3 patents)

28 patents: Sort by Forward Citations

1. 12078636 - Selective white blood cell lysis for immunoassay systems (2024-09-03),

2. 11002734 - Methods and devices for using mucolytic agents including N-acetyl cysteine (NAC) (2021-05-11),

3. 10808287 - Methods and devices for accurate diagnosis of infections (2020-10-20),

4. 10413587 - Histatin for corneal wound healing and ocular surface disease (2019-09-17),

5. 10408835 - Method and device for combined detection of viral and bacterial infections (2019-09-10),

6. 10379121 - Method and device for combined detection of viral and bacterial infections (2019-08-13),

7. 9939434 - Multiplanar lateral flow assay with sample compressor (2018-04-10),

8. 9933423 - Method and device for combined detection of viral and bacterial infections (2018-04-03),

9. 9910036 - Method and device for combined detection of viral and bacterial infections (2018-03-06),

10. 9804155 - Methods and devices for using mucolytic agents including N-Acetyl Cysteine (NAC) (2017-10-31),

11. 9797898 - Methods and devices for using mucolytic agents including N-acetyl cysteine (NAC) (2017-10-24),

12. 9372192 - Method and device for combined detection of viral and bacterial infections (2016-06-21),

13. 9250236 - Method to increase specificity and/or accuracy of lateral flow immunoassays (2016-02-02),

14. 9212386 - Enzymatic cleavage based lateral flow assays (2015-12-15),

15. 9121849 - Lateral flow assays (2015-09-01),

Rapid Pathogen Screening, Inc. is a leading biotechnology company that specializes in developing innovative and rapid diagnostic tests for various infectious diseases. With a focus on improving patient outcomes and reducing healthcare costs, the company offers advanced screening solutions that enable early detection and effective management of pathogens. Rapid Pathogen Screening, Inc. collaborates with healthcare professionals, researchers, and public health agencies to address the global challenge of infectious diseases through cutting-edge technology and reliable diagnostic tools.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

28 Patents

#9 in Sarasota, FL

#288 in Florida

#11,598 in US

#22,555 in the World

Sarasota, FL, United States of America

Rapid Pathogen Screening, Inc.

Forward Citations = 136

18 inventors:

Robert P Sambursky (25 out of 26 patents)

Uma Mahesh Babu (22 out of 23 patents)

Robert W VanDine (22 out of 24 patents)

4. Peter Condon (5 out of 5 patents)

5. Franz Aberl (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…